UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-35628 PERFORMANT FINANCIAL CORPORATION (Exact name of registrant as specified in its charter) Delaware 20-0484934 (State or oth ...

Performant Financial Corporation. (NASDAQ:PFMT) Q2 2022 Earnings Conference Call August 8, 2022 5:00 PM ET Company Participants Richard Zubek - IR Lisa Im - CEO Simeon Kohl - President Rohit Ramchandani - SVP of Finance and Strategy Conference Call Participants George Sutton - Craig-Hallum Kyle Bauser - Lake Street Capital Markets Operator Greetings, and welcome to the Performant Financial Corp. Second Quarter 2022 Earnings Call. [Operator Instructions]. As a reminder, this conference is being recorded. I w ...

PERFORMANT INVESTOR PRESENTATION 2022 Company Overview This document is for educational purposes only and may be updated and this information is provided "as is" without any expressed or implied warranty. Rights and obligations discussed in relation to the information in these materials are non-binding unless and until the parties enter into a signed, legally binding agreement. FORWARD LOOKING STATEMENT This presentation contains certain forward-looking statements within the meaning of the Private Securitie ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Washington, D.C. 20549 Commission File Number: 001-35628 PERFORMANT FINANCIAL CORPORATION (Exact name of registrant as specified in its charter) FORM 10-Q (Mark One) Delaware 20-0484934 (State or ot ...

Financial Data and Key Metrics Changes - In Q1 2022, the company reported total revenues of $27.1 million, with healthcare revenues of $23.4 million, marking a 75% increase compared to the same period last year [10][20] - Adjusted EBITDA for Q1 was $0.3 million, compared to a loss of $0.2 million in the prior year, indicating improved financial performance [23] - Operating expenses in Q1 were $28.6 million, which was $5.9 million lower than Q1 of the previous year [28] Business Line Data and Key Metrics Changes - Healthcare revenues reached $23.4 million, driven by strong growth from implemented statements of work and new program implementations [9][20] - Claims auditing revenues were $9.2 million, an increase of over 70% from $5.4 million in Q1 2021 [25] - Eligibility services revenues were $14.2 million, representing an 80% increase from $7.9 million in the same quarter last year [26] Market Data and Key Metrics Changes - The company anticipates continued growth in healthcare revenues, projecting $92 million to $96 million for 2022 [32] - Customer care outsource services revenues were flat at $3.6 million, impacted by the federal student loan payment pause [21] Company Strategy and Development Direction - The company is focused on executing its growth strategy while adapting to hiring challenges in a competitive market [18] - The recent contract awards, including the HHS OIG IDIQ Contract and the Medicare Recovery Audit program, are expected to enhance the company's capabilities and market position [7][16] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the recovery from COVID-related restrictions and the potential for increased utilization rates [10][31] - The company remains cautious about the macroeconomic environment and its impact on larger Managed Care Organizations (MCOs) [31] Other Important Information - The company is currently navigating the appeal process for the Region 2 contract, which is under review by CMS [12][44] - The hiring strategy has been adjusted to meet the demands of new contracts, particularly for skilled nurses and coders [18] Q&A Session Summary Question: Can you discuss the cadence of revenue growth throughout the year? - Management indicated that Q1 results were strong, but they expect sequential growth to be more pronounced in the second half of the year [36] Question: Are there any larger contracts expiring this year? - Management confirmed that there are no larger contracts expiring this year, as most contracts are on auto-renewal [37] Question: What is the status of the OIG contract? - Management stated that it is still early to provide detailed insights, but they are operationalizing the contract with expectations for revenue in 2023 [42] Question: How does winning high-profile contracts affect the sales pipeline? - Management noted that such contracts enhance visibility and credibility, positively impacting the sales pipeline [50] Question: What implications does Anthem's loss of a large hospital have for commercial opportunities? - Management highlighted that managing a comprehensive payment integrity program is complex, presenting opportunities for the company to provide these services [53]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-35628 PERFORMANT FINANCIAL CORPORATION (Exact name of registrant as specified in its charter) Delaware 20-0484934 (State or other ju ...

Performant Financial Corporation (NASDAQ:PFMT) Q4 2021 Earnings Conference Call March 15, 2022 5:00 PM ET Company Participants Richard Zubek - Investor Relations Lisa Im - Chief Executive Officer Simeon Kohl - President Rohit Ramchandani - Senior Vice President of Finance and Strategy Conference Call Participants Kyle Bauser - Colliers Securities George Sutton - Craig-Hallum Operator Greetings, and welcome to Performant Financial Corp. Fourth Quarter 2021 Earnings Call. At this time, all participants are in ...

INVESTOR PRESENTATION 2021 Company Overview PERFORMANT 2 FORWARD LOOKING STATEMENTS This presentation contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding our outlook for revenues, net income (loss), and adjusted EBITDA in 2021 and beyond. These forward-looking statements are based on current expectations, estimates, assumptions and projections that are subject to change and actual results may differ materially ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-35628 PERFORMANT FINANCIAL CORPORATION (Exact name of registrant as specified in its charter) Delaware 20-0484934 (State o ...

Performant Financial Corporation (NASDAQ:PFMT) Q3 2021 Earnings Conference Call November 9, 2021 5:00 PM ET Company Participants Richard Zubek - Investor Relations Lisa Im - Chief Executive Officer Simeon Kohl - Senior Vice President and General Manager of Healthcare Rohit Ramchandani - Senior Vice President of Finance and Strategy Conference Call Participants Kyle Bauser - Colliers Securities Craig Melcher - Tudor Investment Corporation George Sutton - Craig-Hallum Operator Welcome to today's Performant Fi ...